Saga Pure ASA Boosts Stake in Vistin Pharma

Vistin Pharma ASA (DE:VP4) has released an update.

Saga Pure ASA has increased its stake in Vistin Pharma ASA by purchasing 300,000 shares at a price of NOK 22.50 each, bringing its total ownership to 0.9% of the company. The transaction, associated with board member Øystein Stray Spetalen, occurred on August 23, 2024, and was conducted on the Oslo Stock Exchange.

For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.